Nov 14 (Reuters)-
D.Western Therapeutics Institute Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Sep 30, 2019 Sep 30, 2018 Dec 31, 2019
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 451 mln 205 mln 500 mln
(+119.4 pct) (+6.9 pct) (+70.7 pct)
Operating 107 mln loss 599 mln 30 mln
Recurring 99 mln loss 605 mln 20 mln
Net 119 mln loss 568 mln 60 mln
EPS 4.57 yen loss 21.65 yen 2.28 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - D.Western Therapeutics Institute Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4576.T